I disagree that this would leave the same situation or even a comparable situation. Under your scenario, MNTA’s expertise would no longer be available to facilitate FDA approval of the Copaxone ANDA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.